Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3Kinase signalling mechanism

European Journal of Neuroscience

Volumn 22, Issue 5, 2005, Pages 1081-1089

  Elliott, Evan ^a   Atlas, Roee ^a   Lange, Aya ^a   Ginzburg, Irith ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Alzheimer's disease; GSK3 ; Mouse; P19 cells; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; K 252A; LITHIUM; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN TYROSINE RECEPTOR KINASE B; TAU PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO; ENZYME INHIBITORS; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TAU PROTEINS; TIME FACTORS;

EID: 25844490528     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04290.x     Document Type: Article

References (48)

1. Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I. & Iqbal, K. (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl Acad. Sci. USA, 98, 6923-6928.
2. Aronov, S., Aranda, G., Behar, L. & Ginzburg, I. (2001) Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal. J. Neurosci., 21, 6577-6587.
3. Atlas, R., Behar, L., Elliott, E. & Ginzburg, I. (2004) The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3 BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells. J. Neurochem., 89, 613-626.
4. Bain, G., Ray, W.J., Yao, M. & Gottlieb, D.I. (1994) From embryonal carcinoma cells to neurons: the P19 pathway. Bioessays, 16, 343-348.
5. Baki, L., Shioi, J., Wen, P., Shao, Z., Schwarzman, A., Gama-Sosa, M., Neve, R. & Robakis, N.K. (2004) PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J., 23, 2586-2596.
6. Bhat, R.V., Budd Haeberlein, S.L. & Avila, J. (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem., 89, 1313-1317.
7. Brazil, D.P., Yang, Z.Z. & Hemmings, B.A. (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci., 29, 233-242.
8. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. & Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev., 33, 95-130.
9. Burke, M.A. & Bothwell, M. (2003) p75 neurotrophin receptor mediates neurotrophin activation of NF-kappa B and induction of iNOS expression in P19 neurons. J. Neurobiol., 55, 191-203.
10. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., Hidaka, H. & Imahori, K. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem., 265, 5267-5272.
11. Cho, J.H. & Johnson, G. V. (2004) Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J. Neurochem., 88, 349-358.
12. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. & Hemmings, B.A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789.
13. Drewes, G., Lichtenberg-Kraag, B., Doring, F., Mandelkow, E.M., Biernat, J., Goris, J., Doree, M. & Mandelkow, E. (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J., 11, 2131-2138.
14. Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. & Saltiel, A.R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl Acad. Sci. USA, 92, 7686-7689.
15. Fahnestock, M., Garzon, D., Holsinger, R.M. & Michalski, B. (2002) Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? J. Neural Transm. Suppl., 62, 241-252.
16. Ferreira, A., Lu, Q., Orecchio, L. & Kosik, K.S. (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol. Cell Neurosci., 9, 220-234.
17. Gallo, G., Ernst, A.F., McLoon, S.C. & Letourneau, P.C. (2002) Transient PKA activity is required for initiation but not maintenance of BDNF-mediated protection from nitric oxide-induced growth-cone collapse. J. Neurosci., 22, 5016-5023.
18. Gibney, J. & Zheng, J.Q. (2003) Cytoskeletal dynamics underlying collateral membrane protrusions induced by neurotrophins in cultured Xenopus embryonic neurons. J. Neurobiol., 54, 393-405.
19. Gong, C.X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I. & Iqbal, K. (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem., 275, 5535-5544.
20. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.C., Zaidi, M.S. & Wisniewski, H.M. (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem., 261, 6084-6089.
21. Gustke, N., Steiner, B., Mandelkow, E.M., Biernat, J., Meyer, H.E., Goedert, M. & Mandelkow, E. (1992) The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett., 307, 199-205.
22. Hardy, J. & Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356.
23. Hetman, M., Cavanaugh, J.E., Kimelman, D. & Xia, Z. (2000) Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J. Neurosci., 20, 2567-2574.
24. Illenberger, S., Zheng-Fischhofer, Q., Preuss, U., Stamer, K., Baumann, K., Trinczek, B., Biernat, J., Godemann, R., Mandelkow, E.M. & Mandelkow, E. (1998) The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell, 9, 1495-1512.
25. Johnson, G.V. & Hartigan, J.A. (1999) Tau protein in normal and Alzheimer's disease brain: an update. J. Alzheimers Dis., 1, 329-351.
26. Koizumi, S., Contreras, M.L., Matsuda, Y., Hama, T., Lazarovici, P. & Guroff, G. (1988) K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells. J. Neurosci., 8, 715-721.
27. Lee, C.W., Lau, K.F., Miller, C.C. & Shaw, P.C. (2003) Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines. Neuroreport, 14, 257-260.
28. Li, G., Yin, H. & Kuret, J. (2004) Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J. Biol. Chem., 16, 15938-15945.
29. Liu, S.J., Zhang, A.M., Li, H.L., Wang, Q., Deng, H.M., Netzer, W.J., Xu, H. & Wang, S.Z. (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J. Neurochem., 87, 1333-1344.
30. Lucas, J.J., Hernandez, F., Gomez-Ramos, P., Moran, M.A., Hen, R. & Avila, J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J., 20, 27-39.
31. Maccioni, R.B., Otth, C., Concha, I.I. & Munoz, J.P. (2001) The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur. J. Biochem., 268, 1518-1527.
32. Mai, L., Jope, R.S. & Li, X. (2002) BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J. Neurochem., 82, 75-83.
33. Mandelkow, E.M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J.R. & Mandelkow, E. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett., 314, 315-321.
34. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. & Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA, 82, 4245-4249.
35. Ming, G.L., Wong, S.T., Henley, J., Yuan, X.B., Song, H.J., Spitzer, N.C. & Poo, M.M. (2002) Adaptation in the chemotactic guidance of nerve growth cones. Nature, 417, 411-418.
36. Munoz-Montano, J.R., Moreno, F.J., Avila, J. & Diaz-Nido, J. (1997) Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett., 411, 183-188.
37. Murer, M.G., Yan, Q. & Raisman-Vozari, R. (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol., 63, 71-124.
38. Pap, M. & Cooper, G.M. (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem., 273, 19929-19932.
39. Patapoutian, A. & Reichardt, L.F. (2001) Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol., 11, 272-280.
40. Phillips, H.S., Hains, J.M., Armanini, M., Laramee, G.R., Johnson, S.A. & Winslow, J.W. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron, 7, 695-702.
41. Poo, M.M. (2001) Neurotrophins as synaptic modulators. Nat. Rev. Neurosci., 2, 24-32.
42. Stambolic, V., Ruel, L. & Woodgett, J.R. (1997) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol., 6, 1664-1668.
43. Takashima, A., Noguchi, K., Sato, K., Hoshino, T. & Imahori, K. (1993) Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl Acad. Sci. USA, 90, 7789-7793.
44. Tapley, P., Lamballe, F. & Barbacid, M. (1992) K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene, 7, 371-381.
45. Tian, Q. & Wang, J. (2002) Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals, 11, 262-269.
46. Tong, L., Balazs, R., Thornton, P.L. & Cotman, C.W. (2004) Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J. Neurosci., 24, 6799-6809.
47. Wang, J.Z., Wu, Q., Smith, A., Grundke-Iqbal, I. & Iqbal, K. (1998) Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett., 436, 28-34.
48. Zirrgiebel, U., Ohga, Y., Carter, B., Berninger, B., Inagaki, N., Thoenen, H. & Lindholm, D. (1995) Characterization of TrkB receptor-mediated signaling pathways in rat cerebellar granule neurons: involvement of protein kinase C in neuronal survival. J. Neurochem., 65, 2241-2250.